10-Q: Quarterly report
10-Q: Q2 2024 Earnings Report
8-K: Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
10-Q: Q1 2024 Earnings Report
8-K: Telesis Bio Reports First Quarter 2024 Financial Results
Codex DNA | 8-K: Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
Codex DNA | 8-K: Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
Codex DNA | 8-K: Telesis Bio Reports Third Quarter 2023 Financial Results
Codex DNA | 8-K: Telesis Bio Reports Second Quarter 2023 Financial Results
Codex DNA | 8-K: Telesis Bio Reports First Quarter 2023 Financial Results
Codex DNA GAAP EPS of -$0.28 Beats by $0.13, Revenue of $9.47M Beats by $2.27M
Codex DNA | 8-K: Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
Telesis Bio (NASDAQ:DNAY) Trading 11.4% Higher
Codex DNA | 8-K: Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results
Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results
Codex DNA Sees 4Q Rev $9M >DNAY
Reviewing Telesis Bio (NASDAQ:DNAY) and Arrayit (OTCMKTS:ARYC)
News On Codex DNA Inc. (DNAY) Now Under TBIO
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Reviewing Bionano Genomics (NASDAQ:BNGO) & Telesis Bio (NASDAQ:DNAY)